Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants

0Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This artice is free to access.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness of lutein and zeaxanthin supplementation used for reducing morbidity and mortality in preterm infants, to assess any adverse effects of lutein and zeaxanthin for this purpose, and to consider the effect of the supplementation in terms of route, dose and timing.

Cite

CITATION STYLE

APA

Choo, Y. M., Ahmad Kamar, A., Tengku Kamalden, T. A. F., Looi, M. L., Tan, K., & Lai, N. M. (2016, May 4). Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD012178

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free